Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases
- PMID: 18177923
- DOI: 10.1016/j.semarthrit.2007.10.003
Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases
Abstract
Objectives: To analyze the main characteristics of adults with sickle cell disease (SCD) and concurrent connective tissue disease (CTD).
Methods: A retrospective investigational study was performed. CTD was diagnosed according to standard international criteria. Severity of SCD was assessed by a clinical severity score.
Results: Thirty patients, 23 women (76%) and 7 men, with hemoglobin S/S (n = 25) or S/C (n = 5) SCD were included. The subtypes of CTD were rheumatoid arthritis (RA) (n = 15), definite systemic lupus erythematosus or "incomplete lupus" requiring treatment (n = 13), primary Sjögren's syndrome with central nervous system involvement (n = 1), and systemic sclerosis (n = 1). Twenty-five of the 30 patients (83%) received steroid treatment, and 15 (50%) received at least 1 immunosuppressive agent (methotrexate in 14 cases) to control CTD. Four RA patients were given antitumor necrosis factor (TNF)alpha and 1 was treated with rituximab without SCD exacerbation. After a median follow-up of 4.5 years [range: 6 months to 30 years] from CTD diagnosis, 11 of the 25 (44%) patients receiving steroids had at least 1 episode of severe infection (mostly due to Staphylococcus aureus or Escherichia coli). SCD exacerbated in 13 of the 30 (43%) patients after CTD onset; 12 of these patients were receiving prednisone and/or methotrexate. Six patients (20%) had died from sepsis (n = 2), stroke (n = 2), or acute chest syndrome (n = 2).
Conclusions: CTD-related clinical manifestations and outcome were not particularly severe in patients with SCD. However, those with active CTD and undergoing steroid +/- methotrexate treatment had more serious SCD-related manifestations, a higher rate of severe infections, and an overall patient mortality rate of 20%. Thus, the management of patients with CTD and underlying SCD should consider the risk/benefit ratio of each treatment and steroid-sparing strategies should be implemented.
Similar articles
-
Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):99-104. doi: 10.1080/09273940701299354. Ocul Immunol Inflamm. 2007. PMID: 17558834
-
Clinical features of lung cancer in patients with connective tissue diseases: a 10-year hospital based study.Respir Med. 2008 Apr;102(4):620-4. doi: 10.1016/j.rmed.2007.10.022. Epub 2008 Jan 4. Respir Med. 2008. PMID: 18178071
-
Pneumocystis carinii pneumonia in patients with connective tissue disease.J Clin Rheumatol. 2006 Jun;12(3):114-7. doi: 10.1097/01.rhu.0000221794.24431.36. J Clin Rheumatol. 2006. PMID: 16755237
-
[Management of sickle cell disease].Rev Prat. 2004 Sep 30;54(14):1557-64. Rev Prat. 2004. PMID: 15558966 Review. French.
-
Big strokes in small persons.Arch Neurol. 2007 Nov;64(11):1567-74. doi: 10.1001/archneur.64.11.1567. Arch Neurol. 2007. PMID: 17998439 Review.
Cited by
-
Juvenile idiopathic arthritis coexisting with sickle cell disease: two case reports.BMJ Case Rep. 2011 Dec 1;2011:bcr1020114889. doi: 10.1136/bcr.10.2011.4889. BMJ Case Rep. 2011. PMID: 22674952 Free PMC article.
-
Cardiac Tamponade in Concurrent Sickle Cell Disease and Systemic Lupus Erythematosus: An Unusual Association.Cureus. 2024 Feb 29;16(2):e55285. doi: 10.7759/cureus.55285. eCollection 2024 Feb. Cureus. 2024. PMID: 38558658 Free PMC article.
-
Rheumatoid arthritis in patient with homozygous haemoglobin C disease.Rheumatol Int. 2011 Jun;31(6):801-3. doi: 10.1007/s00296-009-1230-y. Epub 2009 Oct 25. Rheumatol Int. 2011. PMID: 19855969
-
A Review of the Relationship between the Immune Response, Inflammation, Oxidative Stress, and the Pathogenesis of Sickle Cell Anaemia.Biomedicines. 2023 Aug 29;11(9):2413. doi: 10.3390/biomedicines11092413. Biomedicines. 2023. PMID: 37760854 Free PMC article. Review.
-
Lupus nephritis in a patient with sickle cell disease.Case Rep Hematol. 2013;2013:907950. doi: 10.1155/2013/907950. Epub 2013 Nov 7. Case Rep Hematol. 2013. PMID: 24312737 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical